These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 18573712)

  • 41. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
    Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
    Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
    Lindenbaum ES; Feitelberg AL; Tendler M; Beach D; Gamliel-Lazarovich A; Har-Shai Y; Hirshowitz B
    Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC; Kwon OS; Yeon JH; Shin HS; Kim BY; Ro BI; Cho HK; Sim WY; Lew BL; Lee WS; Park HY; Hong SP; Ji JH
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM;
    Dermatology; 2004; 209(3):202-7. PubMed ID: 15459533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated.
    Rapaport MJ
    Dermatol Surg; 2004 May; 30(5):761-3. PubMed ID: 15099321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.
    Hoffmann R
    Eur J Dermatol; 2001; 11(4):362-8. PubMed ID: 11399546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
    D'Amico AV; Roehrborn CG
    Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Female-patterned alopecia in teenage brothers with unusual histologic features.
    Carlson JA; Malysz J; Schwartz J
    J Cutan Pathol; 2006 Nov; 33(11):741-8. PubMed ID: 17083694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
    Mella JM; Perret MC; Manzotti M; Catalano HN; Guyatt G
    Arch Dermatol; 2010 Oct; 146(10):1141-50. PubMed ID: 20956649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.
    Keene S; Goren A
    Dermatol Ther; 2011; 24(2):296-300. PubMed ID: 21410621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
    Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J
    J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
    Boersma IH; Oranje AP; Grimalt R; Iorizzo M; Piraccini BM; Verdonschot EH
    Indian J Dermatol Venereol Leprol; 2014; 80(6):521-5. PubMed ID: 25382509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.
    Piraccini BM; Blume-Peytavi U; Scarci F; Jansat JM; Falqués M; Otero R; Tamarit ML; Galván J; Tebbs V; Massana E;
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):286-294. PubMed ID: 34634163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment.
    Hoffmann R; Happle R
    Eur J Dermatol; 2000; 10(5):410-7. PubMed ID: 10882953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.
    Whiting DA; Waldstreicher J; Sanchez M; Kaufman KD
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):282-4. PubMed ID: 10674382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
    Khandpur S; Suman M; Reddy BS
    J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.